Mergers & Acquisitions
🇺🇸 FDA Page 5FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma M&A deals, divestitures, and partnerships. Gain critical intelligence for strategic investment and business development in life sciences.
Showing 49–60 of 73 articles
Healthcare Dealmakers Target Megamergers in 2026
Fierce Pharma Asia: Key Insights on Recent Deals and Trends
Pfizer and Innovent's $10B Cancer Drug Deal: Key Insights
Trump's Pharma Deals Under Scrutiny: Insights and Implications
Trump Drug Pricing Deals Face New Launches
AstraZeneca's Breast Cancer Pill and ADAP Deal Insights
CordenPharma Expands Production Capacity with New CDMO Deal
Eli Lilly's New Gene Therapy and Strategic Deals: Insights for Investors
Lantheus Considers $7B Acquisition of Curium: Implications for Pharma
Impact of COINS Act Expansion on China Biotech Licensing
SK bioscience's $260M Deal for Varicella Vaccine Production in Colombia
GOP Lawmaker Urges Action on China Biotech Deals